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Abstract  
 
Neutrophils play a central role in host defenses against infectious microbial pathogens.  
However, molecular basis for their triggering signals has been incompletely understood.  
Here, we show molecular and functional characteristics of myeloid-associated 
immunoglobulin-like receptor (MAIR)-IV.  MAIR-IV was preferentially expressed on 
neutrophils in the peripheral blood, bone marrow, peritoneal cavity and spleen.  
MAIR-IV physically associates with immunoreceptor tyrosine based activating motif 
(ITAM)-bearing adaptor FcRγ chain.  Cross-linking MAIR-IV with anti-MAIR-IV 
monoclonal antibody significantly induced secretion of proinflammatory cytokines 
TNF-α and IL-6 from neutrophils.  Thus, MAIR-IV may regulate activation of 
neutrophils and play an important role for innate immunity.   
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1. Introduction 
 
Myeloid cells, including neutrophils and macrophages, play an essential role for host 
defenses against infectious microbial pathogens (Nathan, 2006).  In response to 
inflammatory stimuli, neutrophils are activated through a vast array of cell surface 
receptors, such as Fc receptors for IgG, β2 integrins, complement receptors, chemokines, 
cytokine receptors and Toll-like receptors, and mediate phagocytosis, degranulation of 
anti-microbial substances or secretion of inflammatory mediators.  However, the 
molecular interactions that trigger anti-microbial functions of neutrophils are 
incompletely understood. 
 
We have recently identified paired activating and inhibitory receptors, 
myeloid-associated immunoglobulin (Ig)-like receptor (MAIR)-I and MAIR-II 
(Yotsumoto et al., 2003), which are also named as CLM8/LMIR1 and 
CLM4/LMIR2/DIgR1, respectively (Luo et al., 2001)(Kumagai et al., 2003)(Chung et 
al., 2003).  MAIR-I is preferentially expressed on myeloid cells, including 
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macrophages, neutrophils, dendritic cells (DC) and bone marrow-derived cultured mast 
cells (Yotsumoto et al., 2003) and mediates an inhibitory signal through 
immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic portion.  
On the other hand, MAIR-II, expressed on macrophages, associates with either 
immunoreceptor tyrosine-based activating motif (ITAM)-containing adaptors DAP12 or 
FcRγ chain and mediates an activating signal, resulting in inflammatory cytokine 
secretion from macrophages (Yotsumoto et al., 2003)(Nakahashi et al., 2007).  By 
screening a database for the mouse genome, we and others found that MAIR-I and 
MAIR-II are members of a multigene family consisting of nine genes on a small 
segment of mouse chromosome 11 (our unpublished observation and (Chung et al., 
2003)).   
 
In this study, we generated monoclonal antibodies (mAbs) against a member of the 
family, MAIR-IV, and investigated its cellular distribution and functional role in 
immune responses.  We show that MAIR-IV is a novel triggering receptor on 
neutrophils and is involved in inflammatory responses. 
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2. Materials and methods 
 
2.1. Antibodies 
Anti-MAIR-IV mAbs TX-69 and TX81 (rat IgG2a and IgG2b, respectively) were 
generated and F(ab’)2 fragments of TX-69 mAb were prepared in our laboratory, as 
described (Yotsumoto et al., 2003).  Alexa Fluor 647-conjugated F(ab’)2 fragments of 
TX69 was prepared by using Alexa Fluor 647 monoclonal antibody labeling kit 
(Molecular Probes, Eugene, Oregon).  Control rat and mouse IgG, anti-CD11b (Mac-1), 
anti-Ly6G (Gr-1), anti-B220, anti-CD3, anti-CD11c, DX-5, and anti-CD32/16 (2.4G2) 
mAbs were purchased from BD Biosciences (San Jose, CA).  Anti-Flag mAb, 
anti-FcεRIγ (FcRγ chain) mAb and horse-radish peroxidase (HRP)-conjugated 
streptavidin (SA) were purchased from Sigma-Aldrich (St Louis, MO), Upstate 
Biotechnology (Lake Placid, NY) and Amersham Biosciences (Piscataway, NJ), 
respectively.  To exclude endotoxin contamination, all antibodies were treated with 
Polymyxin B (BIO-RAD, CA), resulting in endotoxin contamination at less than 100 
pg/mg of mAb, as determined by Limulus Color KY Test (Wako, Osaka, Japan). 
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2.2. Mice, Cells and transfectants 
FcRγ-/- mice were provided by T. Takai (Tohoku University, Sendai, Japan). C57BL/6J 
mice were purchased from Clea Japan (Tokyo, Japan). Neutrophils from the bone 
marrow were purified by using a MACS selection system using biotin-labeled anti-Gr-1, 
followed by streptavidin-MicroBeads (Miltenyi Biotec, Bergisch Granbach, Germany) 
and those from peritoneal cavity were collected 6 hrs after the 2.4% thioglycollate i.p. 
injection.  Macrophages, dendritic cells (DC) and mast cells were generated by culture 
of BM cells in the presence of M-CSF (50 ng/ml) for 5 days, GM-CSF (10 ng/ml) for 9 
days and IL-3 (4 ng/ml) plus SCF (10 ng/ml) for 5 weeks, respectively.  Purity of each 
lineage of cells was more than 95%, as determined by flow cytometry.  All 
experiments were performed according to the guidelines of the animal ethics committee 
of the University of Tsukuba.  BW5147, RAW264.7 and RBL-2H3 transfectants stably 
expressing MAIR-IV, MAIR-II or MAIR-V were established, as described (Yotsumoto 
et al., 2003).  
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2.3. Immunoprecipitation and western blotting 
To analyze association of MAIR-IV with FcRγ chain, RAW264 or RBL-2H3 
transfectants, or peritoneal exudative macrophages were lysed with a lysis buffer 
containing 1% digitonin (Calbiochem, San Diego, CA), 0.12% Triton-X 
(Sigma-Aldrich), 150 mM NaCl, 20 mM triethanolamine and protease inhibitors.  
Lysates were subjected to immunoprecipitation with anti-Flag M2 affinity gel (Sigma 
Aldrich), anti-MAIR-IV mAb (TX81) or isotype-matched rat IgG.  Immunoprecipitates 
were separated by SDS-PAGE under reducing condition, transferred (60V in 25mM Tris, 
195mM glycine, and 20% methanol) to PVDF membranes (Immobilon-PSQ; Millipore, 
Billerica, MA).  Membranes were incubated overnight in TBST (10mM Tris-buffered 
saline containing 0.5% Tween 20, 0.5g/l MgCl2, pH8.0), containing 3% bovine serum 
albumin (BSA) for blocking, and incubated with primary antibodies.  Proteins were 
detected by using HRP-conjugated anti-rabbit IgGs or anti-rat IgGs (Amersham 
Biosciences, Piscataway, NJ), and were developed with SuperSignal CL-HRP substrate 
(Piece Chemical Co.).  For stripping and re-blotting, Restore Western Blot Stripping 
Buffer (Piece Chemical Co.) was used according to the manufacture’s instruction.      
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2.4. Cytokine production  
Peritoneal exudative cells (PECs) and neutrophils were stimulated with plate-coated 
F(ab’)2 fragments of anti-MAIR-IV mAb (TX69) or control IgG and culture 
supernatants were subjected to ELISA assay for TNF-α and IL-6 (BD Biosciences, San 
Jose, CA).  
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3. Results and discussion 
 
3.1. Identification of MAIR-IV 
We cloned all the full-length cDNAs of the MAIR family genes other than MAIR-I and 
MAIR-II by PCR from the spleen of C57BL/6 mice and designated them as MAIR-III 
to MAIR-IX, based on a phylogenetic tree analysis (Fig1A, B).  The MAIR family was 
found to be a murine counterpart of the human CMRF-35 (CD300) family (Cantoni et 
al., 1999)(Clark et al., 2000)(Clark et al., 2002), which is located on human 
chromosome 17, syntenic region of mouse chromosome 11 (Fig 1A).  We found that 
one of the genes, MAIR-IV, has a short cytoplasmic tail (24 aa) with no signaling motif 
and a negatively charged glutamic acid (E) in its transmembrane (TM) region.  The 
Ig-like domain of MAIR-IV in the extracellular portion has 91% identity with that of 
MAIR-V at the amino acid level.  In contrast to MAIR-IV, MAIR-V has a long 
cytoplasmic tail containing two consensus immunoreceptor tyrosine-based inhibitory 
motif (ITIM), suggesting that MAIR-IV and MAIR-V constitute paired activating and 
inhibitory receptors.   
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3.2. MAIR-IV is preferentially expressed on neutrophils and macrophages 
MAIR-IV and MAIR-V were also named as CLM5 and CLM1/DIgR2 (Chung et al., 
2003)(Fujimoto et al., 2006)(Shi et al., 2006), respectively.  Although expression of 
MAIR-IV/CLM5 mRNA was reported to be detected in myeloid cells (Fujimoto et al., 
2006), its protein expression profile has been undetermined because of lack of 
monoclonal antibodies.  Therefore, functional characteristics of MAIR-IV in immune 
responses has remained unclear.  Here, we generated monoclonal antibodies (TX69 
and TX81 mAbs) against MAIR-IV by immunizing a rat with a mouse T cell leukemia 
cell line BW5147 transfected with Flag-tagged MAIR-IV.  To confirm the specificity of 
these mAbs to MAIR-IV, we also established BW5147 transfectant stably expressing 
MAIR-I, MAIR-II, MAIR-V tagged with Flag at the N-terminus.  TX69 and TX81 
mAbs specifically stained the transfectant expressing MAIR-IV, but not those 
expressing MAIR-I, MAIR-II or MAIR-V, indicating that these mAbs are specific to 
MAIR-IV (Fig 2A and data not shown).  Analyses by flow cytometry by using 
Alexa-657-conjugated F(ab’)2 fragments of TX69 mAb showed that MAIR-IV was 
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preferentially expressed on Gr-1high/Mac-1+ neutrophils from the peripheral blood, bone 
marrow, peritoneal cavity and spleen (Fig.2B).  MAIR-IV was also expressed on 
Mac-1+/Gr-1- macrophages from the spleen and bone marrow and CD11c+ dendritic 
cells (DC), but not on T, B, NK cells or bone marrow-derived cultured mast cells 
(Fig.2B).   
 
3.3. FcRγ chain physically associates with MAIR-IV and is involved in cell surface 
expression of MAIR-IV in primary cells 
MAIR-IV contains a short cytoplasmic tail with no signaling motif, suggesting that 
MAIR-IV, like MAIR-II, mediates activating signals via ITAM-containing adapter 
proteins, such as FcRγ chain or DAP12.  These adaptor proteins are expressed in 
myeloid cells and characterized by a small extracellular region, a negatively charged 
amino acid aspartic acid (D) in the TM domain, and a cytoplasmic domain that contains 
two ITAMs (Feng et al., 2005).  DAP12 associates with several activating NK 
receptors and myeloid cell-specific receptors, including human and mouse TREM-1, 
TREM-2, MDL-1, and PILRβ, SIRPβ1, mouse TREM-3 and CD200R3, CD200R4 and 
mouse MAIR-II, all of which contain a positively charged amino acid, such as lysine 
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(K) or arginine (R), in their TM region (Takaki et al., 2006). In contrast, FcRγ chain is 
also able to associate with receptors, such as FcγRIIIA and FcεRI, which do not contain 
a positively charged amino acid in the TM region (Kim et al., 2003)(Varin-Blank and 
Metzger, 1990).  Because MAIR-IV does not possess a positively charged amino acid 
in the TM region, FcRγ chain might be a partner of MAIR-IV.  In fact, a recent report 
by Fujimoto et al showed that the transfection of FcRγ chain enhanced cell surface 
expression of co-transfected Flag-tagged MAIR-IV/CLM-5 in HEK293T cells, 
suggesting that MAIR-IV/CLM5 might associate with FcRγ chain (Fujimoto et al., 
2006).  To examine whether MAIR-IV physically associates with the FcRγ chain, a 
macrophage cell line, RAW264, which expressed the endogeneous FcRγ chain, was 
transfected with MAIR-IV or MAIR-V tagged with Flag.  As demonstrated in Fig 3A, 
MAIR-IV, but not MAIR-V, was coimmunoprecipitated with FcRγ chain.  We also 
transfected a rat basophilic leukemia cell line, RBL-2H3, with DAP12 tagged with Flag.  
Whereas MAIR-II was coimmunoprecipitated with DAP12, as previously reported by 
our group (Yotsumoto et al., 2003)(Nakahashi et al., 2007), MAIR-IV was not (Fig 3B).  
These results indicated the physical association of transfected MAIR-IV with the FcRγ 
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chain, but not with DAP12, in these transfectants.  Furthermore, we also found that 
endogeneous MAIR-IV was also coimmunoprecipitated with FcRγ chain in lysates of 
peritoneal macrophages stimulated with thioglycollate from wild type (WT), but not 
FcRγ -/-, mice. In addition, cell surface expression of MAIR-IV was significantly 
down-regulated on bone marrow and peritoneal neutrophils from FcRγ -/- mice, 
compared with those from WT mice (Fig. 3D).  Moreover, although intraperitoneal 
treatment with thioglycollate significantly up-regulated cell surface expression of 
MAIR-IV on macrophages, this enhancement was not detected on those from FcRγ -/- 
mice (Fig. 3D).  Because mRNA expression of MAIR-IV in FcRγ -/- peritoneal 
macrophages was comparable to that in WT peritoneal macrophages (data not shown), 
cell-surface expression of MAIR-IV largely depended on FcRγ chain expression.  
Taken together, these results indicated that FcRγ chain physically associates with 
MAIR-IV and is involved in cell surface expression of MAIR-IV in primary neutrophils 
and macrophages.  
 13 
  Nakano T, et al 
 
3.4. MAIR-IV is a triggering receptor on neutrophils  
Because MAIR-IV associates with FcRγ chain, it may mediates an activating signal in 
neutrophils.  To address this issue, neutrophils were purified from the BM and 
peritoneal cavity and stimulated with plate-coated F(ab’) 2 fragments of anti-MAIR-IV 
mAb.  As shown in Fig. 4A, TNF-α secretion from neutrophils was significantly 
increased after the stimulation with anti-MAIR-IV.  Similarly, stimulation of PEC with 
plate-coated F(ab’) 2 fragments of anti-MAIR-IV mAb significantly augmented 
secretion of IL-6 as well as TNF-α (Fig. 4B).  These results indicated that MAIR-IV is 
a novel activating receptor on neutrophils.  Thus, MAIR-IV may regulate neutophils 
activation and involved in innate immunity.  To clarify the in vivo role of MAIR-IV in 
immune responses, identification of the ligand for MAIR-IV should be required.  
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Figure Legends 
 
Figure 1. Chromosomal localization and molecular phylogenetic tree of MAIR 
gene family. 
(A) Chromosomal localization of mouse and human MAIR families on chromosome 11 
and 17, respectively, were determined based on the data from National Center for 
Biotechnology Information Map Viewer site. (B) Phylogenetic analysis of the MAIR 
family genes was performed by using the UPGMA method of GENETYX-MAC 
software (Software develoment, Tokyo, Japan).  
 
Figure 2. Expression of MAIR-IV on hematopoietic cells.  
(A) BW5147 parent cells or transfectants expressing Flag-tagged MAIR proteins 
indicated were stained with anti-Flag mAb (open histgrams of the upper panel) or 
Alexa-647-conjugated F(ab’)2 fragments of TX69 mAb (open histograms of the lower 
panel).  Shaded histograms shows negative controls with isotype-matched control IgGs. 
(B) Peripheral blood, spleen, bone marrow (BM), peritoneal exudative cells (PEC), 
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BM-derived cultured macrophages, dendritic cells (DC) and mast cells from C57BL/6 
mice were stained with Alexa-647-conjugated F(ab’)2 fragments of TX69 mAb (open 
histograms) or F(ab’)2 fragments of isotype-matched control antibodies (shaded 
histograms) in combination with lineage-specific mAbs indicated.  Cells were gated 
according to lineage markers expression by flow cytometry.  
 
Figure 3. MAIR-IV associates with FcRγ.  
(A) RAW264 cells or transfectants expressing Flag-tagged MAIR-IV or MAIR-V were 
lysed and immunoprecipitated with anti-Flag and proteins were immunoblotted with 
anti-Flag or anti-FcRγ. (B) RBL-2H3 cells were transfected with Flag-tagged DAP12 
alone or in combination with MAIR-IV or MAIR-II.  These transfectants were lysed 
and immunoprecipitated with anti-MAIR-IV (TX81) or anti-MAIR-II (TX10) mAbs 
and proteins were immunoblotted with anti-MAIR-IV (TX69) or anti-Flag mAb. (C) 
Macrophages were collected from peritoneal cavity of WT or FcRγ-/- mice 4 days after 
i.p. treatment with thioglycollate, lysed and immunoprecipitated with anti-MAIR-IV 
mAb (TX81).  Immunoprecipitates were immunoblotted with anti-MAIR-IV (TX69) 
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or anti-FcRγ mAbs. (D) Neutrophils were purified from BM and peritoneal cavity from 
WT or FcRγ-/- mice 6 hrs after i.p. treatment with thioglycollate.  Macrophages were 
collected from peritoneal cavity of WT or FcRγ-/- mice before or 4days after i.p. 
treatment with thioglycollate.  Cells were stained with Alexa647-conjugated F(ab’)2 
fragments of anti-MAIR-IV (TX69), PE-conjugated anti-Gr-1, and FITC-conjugated 
anti-Mac-1 mAbs. 
 
Figure 4. MAIR-IV triggers secretion of inflammatory cytokines from neutrophils 
macrophages.  
BM and peritoneal neutrophils (A) and resident peritoneal macrophages (B) were 
stimulated with either plate-coated F(ab’) 2 fragments of anti-MAIR-IV (TX69) or 
isotype-matched control mAbs for 12 hrs and 24 hrs, respectively, and TNF-α and IL-6 
concentrations in the supernatants were measured by ELISA.  * and ** indicate p<0.05 
and p<0.01, respectively, as analysed by Student’s t-test.  Data are respresentative from 
three independent experiments. 
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